CETIRIZINE HYDROCHLORIDEtablet [Physicians Total Care, Inc.]
Updated Date: Oct 21, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
The management of EGFR inhibitor adverse events: a case series and treatment paradigm.
Conclusion The most common cutaneous adverse event in our cohort was papulopustular rash, followed by eczema and xerosis. Patients were managed with symptom target therapy, and suspension of the EGFR inhibitor was rarely required. As the use of EGFR inhibitors increases, it is important to promptly identify and treat adverse events. Further studies are necessary to develop targeted therapeutic and preventative measures.
PMID: 22250636 [PubMed - in process] (Source: Herpes)
